Abstract
Alcohol use disorder (AUD) is a chronically relapsing disease characterized by loss of control in seeking and consuming alcohol (ethanol) driven by the recruitment of brain stress systems. However, AUD differs among the sexes: men are more likely to develop AUD, but women progress from casual to binge drinking and heavy alcohol use more quickly. The central amygdala (CeA) is a hub of stress and anxiety, with corticotropin-releasing factor (CRF)-CRF1 receptor and Gamma-Aminobutyric Acid (GABA)-ergic signaling dysregulation occurring in alcohol-dependent male rodents. However, we recently showed that GABAergic synapses in female rats are less sensitive to the acute effects of ethanol. Here, we used patch-clamp electrophysiology to examine the effects of alcohol dependence on the CRF modulation of rat CeA GABAergic transmission of both sexes. We found that GABAergic synapses of naïve female rats were unresponsive to CRF application compared to males, although alcohol dependence induced a similar CRF responsivity in both sexes. In situ hybridization revealed that females had fewer CeA neurons containing mRNA for the CRF1 receptor (Crhr1) than males, but in dependence, the percentage of Crhr1-expressing neurons in females increased, unlike in males. Overall, our data provide evidence for sexually dimorphic CeA CRF system effects on GABAergic synapses in dependence.
Keywords: corticotropin releasing factor (CRF), patch-clamp electrophysiology, sex difference, alcohol use disorder (AUD), Gamma-Aminobutyric Acid (GABA), central amygdala (CeA), spontaneous inhibitory postsynaptic currents (sIPSCs)
1. Introduction
Alcohol use disorder (AUD) is a chronically relapsing disorder characterized by a preoccupation with alcohol consumption, a loss of control in limiting intake, and the emergence of negative emotional states during withdrawal (also known as hyperkatifeia, which includes dysphoria, anxiety, irritability) [1,2]. Excessive alcohol consumption associated with negative emotional states observed in withdrawal occurs via negative reinforcement mechanisms such that alcohol alleviates the symptoms of withdrawal [3,4,5,6,7]. Thus, brain regions, such as the central nucleus of the amygdala (CeA), that are involved in processing stress, anxiety, and other withdrawal-associated states are recruited in the development of AUD. The CeA is a primarily Gamma-Aminobutyric Acid (GABA) -ergic nucleus that was shown to be involved in excessive alcohol consumption related to dependence and withdrawal, across species [8,9,10,11].
The CeA also contains many neuropeptide systems that modulate synaptic activity. The peptide corticotropin-releasing factor (CRF), a key mediator of stress responses, is locally produced and released by neurons within multiple brain regions, including the hypothalamus, the CeA, and other afferent regions [12]. CRF is a 41-residue polypeptide that binds to the G-protein-coupled CRF type 1 (CRF1) and CRF type 2 (CRF2) receptors [13,14]. While CRF produces its effects by binding to both receptors, it has a greater affinity for CRF1 [12,15]. The role of the CRF1 system was characterized in multiple rodent models of alcohol dependence. For example, ethanol withdrawal increased CRF levels in the amygdala of rats [16]. In alcohol-dependent rats, chronic treatment with a CRF1 antagonist blocked alcohol withdrawal-induced increases in alcohol drinking, and in non-dependent rats, the CRF1 antagonist tempered moderate increases in alcohol consumption [17]. In addition, the escalation of alcohol self-administration and anxiety typically observed during protracted abstinence can be blocked by competitive CRF1 antagonists [18,19,20,21].
Despite preclinical evidence suggesting that CRF1 antagonists would be efficacious in the treatment of alcohol dependence, clinical trials of CRF1 antagonist-based therapies to treat AUD in humans have shown mixed results [22,23]. Thus, more work is needed to fully understand the neuroadaptations that facilitate and sustain alcohol dependence, and in particular, the impact of sex on the underlying neurobiology of the disease. Potential sex differences are especially important considering the heightened activity of stress- and anxiety-related brain regions in alcohol dependence, and the inherent sex differences in stress responses [24,25]. Many neuropsychiatric disorders, including anxiety disorders and stress- and trauma-related disorders, differ by sex [26,27,28], and preclinical studies have shown differences in stress and anxiety processing between males and females [24]. More recently, transgenic reporter mice have been used to study sex differences in the CRF1 system [29], and while dependence was shown to sensitize females to the effects of acute alcohol [30], to our knowledge, no one has studied the neuroadaptations in the female CeA CRF system during alcohol dependence.
In this study, we induced alcohol dependence in rats using an established model of chronic intermittent ethanol vapor exposure and used whole-cell patch-clamp electrophysiology and in situ hybridization (ISH) to identify sex-specific neuroadaptations in the regulatory function of CRF at GABAergic synapses. Within the CeA of naïve and dependent rats of each sex, we determined the effects of the exogenous acute application of different concentrations of CRF and assessed tonic CRF1 receptor activity (using a selective CRF1 antagonist, R121919) on spontaneous inhibitory GABAergic postsynaptic currents (sIPSCs). We also determined the levels of mRNA co-expression of the CRF1 receptor with GABAergic neuronal markers in the CeA in both sexes.
2. Results
2.1. Sex Differences in Baseline sIPSC Kinetics of CeA GABA Synapses
We performed whole-cell patch-clamp recordings of GABAergic sIPSCs (Figure 1A) from neurons (n = 132) in the medial subdivision of the CeA of both male (left) and female (right), naïve (top) and alcohol-dependent (bottom) rats. In line with our previous results [30], here we found no main effect of sex or alcohol exposure on baseline sIPSC frequency (Figure 1B), amplitude (Figure 1C), or rise time (Figure 1D). Furthermore, our results revealed a main effect of alcohol exposure on sIPSC decay time (two-way ANOVA; Alcohol Exposure F1,132 = 14.2, p < 0.001) as dependent animal groups had higher decay times on average (10.94 ms) compared to naïve animal groups (8.66 ms) (as in [30]) (Figure 1E). Additionally, there was neither a main effect of Sex nor a Sex × Alcohol Exposure interaction effect, and no main effect of Sex or Alcohol Exposure on charge transfer (i.e., sIPSC area; see Figure A1 in Appendix A). These data suggest that alcohol dependence is altering postsynaptic GABAA receptor function.
2.2. Alcohol Dependence Induces Responsivity of Female CeA GABAergic Synapses to Acute CRF Application
We next investigated the effects of acute CRF on CeA sIPSCs of both sexes (Figure 2A,B), at a concentration previously determined to have a maximal effect in males (200 nM, [17]). We found a significant main effect of Alcohol Exposure on sIPSC frequency (two-way ANOVA; F1,37 = 5.01, p < 0.05; Figure 2C) such that in alcohol-dependent groups, acute application of CRF significantly increased the sIPSC frequency (as a percent of baseline; see Table A1 in Appendix A for raw values) to a larger extent than in naïve groups. While we did not find a significant main effect of sex, there was a significant Sex × Alcohol Exposure interaction effect (two-way ANOVA; F1,37 = 4.37, p < 0.05) driven by naïve females. Specifically, acute application of 200 nM CRF did not significantly increase the sIPSC frequency of naïve females as it did in naïve males (Šídák; t9,12 = 3.09, p < 0.05). There were no significant differences in sIPSC amplitude (Figure 2D), rise time (Figure 2E), or decay time (Figure 2F) across groups. These results indicate that acute CRF enhances presynaptic GABA release in all groups except naïve females and that alcohol dependence induces similar responsivity to acute CRF in males and females.
Given that the sex difference in CRF response was driven by naïve females, we tested lower (100 nM) and higher (400 nM) concentrations of CRF in naïve rats of each sex to compare their responsivity (Figure 3A,B). As shown in Figure 3C, we found the main effect of Sex (two-way ANOVA; F1,53 = 14.34, p < 0.001), but no main effect of CRF concentration on sIPSC frequency (as a percent of baseline; see Table A1 in Appendix A for raw values). However, we do report a Sex × CRF Concentration interaction effect (F1,53 = 3.73, p < 0.05) which was driven by the difference between male and female naïve responses to 200 nM CRF (Sidak; t12,9 = 4.45, p < 0.001). In addition, naïve males responded to low (one-sample t-test, t9 = 3.06, p < 0.05) and high (one-sample t-test, t11 = 2.69, p < 0.05) concentrations of CRF, with a maximally effective concentration of 200 nM (one-sample t-test, t12 = 6.14, p < 0.0001), which recapitulates our previous work. In contrast, we observed no concentration of CRF that produced an effective response in females (one-sample t-test, p > 0.05). Collectively, these results suggest that acute CRF produces concentration-dependent responses in naïve males but not in females. There were no effects of Sex or CRF Concentration on sIPSC amplitude (Figure 3D), rise time (Figure 3E), or decay time (Figure 3F).
We then assessed the CRF sensitivity of male and female dependent rats (Figure 4A,B). Consistent with previous findings [17], high (400 nM) concentrations of CRF increased sIPSC frequency of dependent males (one-sample t-test, t9 = 2.52, p < 0.05) while a low concentration of CRF (100 nM; one-sample t-test, p > 0.05) did not. In addition, high (400 nM) but not low (100 nM) concentrations of CRF also increased sIPSC frequency of dependent females (one-sample t-test, t11 = 5.99, p < 0.001), similar to what we observed in the dependent males (Figure 4C). In contrast to the naïve group, group analysis of dependent rats revealed a significant main effect of CRF Concentration (two-way ANOVA test, F2,51 = 6.19, p < 0.01) on sIPSC frequency (as a percent of baseline; see Table A1 in Appendix A for raw values), but no main effect of Sex and no interaction effect. Additionally, there was no main effect of Sex, no main effect of CRF Concentration, and no interaction effect on sIPSC amplitude (Figure 4D), rise time (Figure 4E), or decay time (Figure 4F). These results indicate that in alcohol dependence, the female CeA becomes responsive to acute CRF, and the CRF concentration responsivity is similar to dependent males.
2.3. Alcohol Dependence Alters CRF1 Receptor Expression in Females
CRF1 receptors mediate most of the effects of CRF on GABA signaling within the CeA [17,31,32]. Given that the CRF responses of GABAergic synapses varied by sex, we investigated whether these differences reflected changes in CRF1 receptor expression in GABAergic neurons in the CeA. To address this, we utilized in situ hybridization (RNAscope) to identify the percent of nuclei expressing CRF1 (Crhr1+), and GAD2 (Gad2+) mRNA in CeA sections of naïve (Figure 5A) and alcohol-dependent (Figure 5B) female and male rats. First, we analyzed the basal CeA expression patterns of Crhr1 in naïve rats of each sex and found that females have significantly fewer Crhr1+ cells relative to males (Figure 5C; p < 0.05). We then determined the expression pattern of Crhr1 in dependent rats. We found that in dependent males, the amount of Crhr1+ cells did not significantly differ from naïve males (Figure 5D); however, female dependent rats had significantly more Crhr1+ cells than naïve females (Figure 5E; p < 0.05). Both female and male rats displayed a high co-expression of Gad2+ in the Crhr1+ cell population (Figure 5F,G). These data suggest that the CeA of naïve female rats has a lower percentage of Crhr1+ cells than naïve males, but alcohol dependence increases the percentage of Crhr1+ cells in females.
2.4. Alcohol Dependence Induces Tonic Activation of CRF1 at CeA GABAergic Synapses in Males Only
Lastly, to compare the basal function of CRF1 on CeA GABA transmission in each sex, we tested the effects of CRF1 selective antagonism [17,33] on sIPSCs via acute application of 1 µM R121919 (Figure 6A). There was no significant main effect of Sex or Alcohol Exposure and no interaction effect on sIPSC frequency (Figure 6B) amplitude (Figure 6C), rise time (Figure 6D), or decay time (Figure 6E). While selective antagonism of CRF1 did not alter CeA GABAergic transmission in naïve males, it significantly decreased GABA release from baseline in dependent male rats (Figure 6B; one-sample t-test, t9 = 2.971, p < 0.05). In contrast to the males, R121919 did not alter sIPSC properties (as a percent of baseline; see Table A1 in Appendix A for raw values) in either naïve or dependent female rats, suggesting that tonic activation of CRF1 may be specific to dependent males.
3. Discussion
In this study, we identified distinct, sexually dimorphic responses of the CRF system on GABAergic synapses in the CeA of naïve and alcohol-dependent rats (see schematic in Figure 7). In brief, we found that CeA neurons of naïve male and female rats display similar baseline presynaptic GABAergic inputs and postsynaptic receptor function. However, alcohol dependence induced an increase in the baseline decay times of postsynaptic GABAA receptor-mediated currents in CeA neurons of both sexes. We recapitulated our previous work [17,34,35] showing that a maximal concentration (200 nM) of CRF increased action-potential dependent GABA release in the CeA of naïve and dependent male rats but found naïve female CeA unresponsive to CRF. We then characterized the effects of high and low CRF concentrations in each sex, which confirmed that naïve females do not respond to CRF. Interestingly, alcohol dependence induced CRF responsivity in females to a similar degree observed in dependent males such that no sex difference was observed. We hypothesized that this heightened responsivity to CRF was due to changes in CRF1 expression in GABAergic neurons in the CeA, which was confirmed via in situ hybridization. Lastly, selective antagonism of CRF1 with R121919 revealed that tonic CRF1 activation, which regulates GABA release, occurred only in dependent males. R121919 had no effect on naïve or dependent females suggesting a lack of tonic CRF signaling in females.
We recently reported the acute alcohol insensitivity of GABAergic CeA neurons in naïve females, which was maintained in alcohol-dependent females except at the highest concentration (88 mM) of ethanol [30]. Here, we found a similar profile in the CRF system such that naïve female CeA neurons were unresponsive to acute CRF, and alcohol dependence induced responsivity in these CeA neurons to high but not low concentrations of CRF. Other studies have reported similar sexually dimorphic effects of the CRF system in the CeA. For example, Rouzer et al. found a Sex × Age interaction in basal spontaneous GABA synaptic transmission within the rat CeA, but only age differences in action potential-independent GABA release [36]. However, sex differences mediated by the selective CRF1 agonist Stressin-1 emerged: opposing effects of Stressin-1 were observed in the action potential-independent GABA release of adolescent and adult males, while in the females there was no change in the response between adolescents and adults [36]. Furthermore, in a study using transgenic CRF1 reporter mice, voluntary alcohol drinking increased the sensitivity of CRF1-positive neurons in the CeA to the effects of acute alcohol in males but not females. In contrast, alcohol drinking increased acute CRF sensitivity of these neurons in both males and females [37]. Tonic CRF activity was also found to be sexually dimorphic, as the CRF1 antagonist R121919 decreased GABA release in water and alcohol-drinking females, but not in either male group [37]. A study by Retson and colleagues also reported sex differences in the CRF system of the rat CeA, which found that alcohol drinking activated CeA CRF neurons and enhanced the response of these neurons to stress selectively in male but not female rats [38].
Here, we found that alcohol dependence increased the CRF responsivity of GABAergic synapses in females while male responses remained elevated. Our results also showed that CRF1 antagonism using R121919 significantly decreased (action-potential dependent) GABA release in dependent males, revealing a basal activity of these receptors in the modulation of CeA GABA transmission after chronic ethanol exposure. In contrast, CRF1 antagonism did not alter basal CeA GABA transmission in either naïve or dependent female rats. A similar difference was seen for action-potential independent GABA release by Rouzer et al., where the CRF1 selective antagonist NBI 35965 increased GABA release in adult male but not female rats [36]. To that end, some limitations of the current study are that we only investigated action-potential dependent GABA transmission in the CeA of adult rats. As such, the role of age in the sexually distinct responses of the CRF system during alcohol dependence remains unclear. Furthermore, our conclusions may not apply to action-potential independent GABA transmission, which are important issues to be addressed in future work. Additionally, given that we found that dependence increased baseline sIPSC decay times without affecting frequency or amplitude, we also assessed the charge transfer (or integrated area) of sIPSCs, but found no differences in inhibitory synaptic activity. Some potential mechanisms underlying this phenomenon include a change in GABA subunit expression [39,40] or a reduction in the expression of a GABA transporter that removes GABA from the synaptic space [41]. Such work is outside the scope of the current study but would be an important area for future investigation.
Some of the discrepancies across studies may be explained by the differential effects produced by alcohol paradigms (i.e., voluntary alcohol drinking vs. vapor-induced alcohol dependence) and the age of the study animals. It is also important to be cautious when drawing comparisons between studies using the CRF peptide and CRF1-selective agonists, as such compounds may produce distinct synaptic responses. That is, CRF as a non-selective agonist can affect both CRF1 and CRF2 receptors, producing changes in synaptic transmission that may not be identical to those induced by the selective CRF1 activation used by Rouzer et al. [36]. However, another important factor to consider is the composition of the cell population being studied, which can be associated with distinct responses. For instance, the Agoglia et al. study specifically targeted CRF1+ neurons in mice [37], while our electrophysiology data come from neurons of unknown CRF1 expression in rats. As our in situ hybridization data show, naïve females have fewer GABAergic neurons expressing CRF1. Thus, our selection of neurons in females was less likely to be CRF1+ than in males. It is possible that the sensitivity of rat CeA CRF1+ neurons to CRF system agonism and antagonism matches that seen in mice, although re-examination of these effects in labeled CRF1+ neurons of rats would need to be performed in future studies to be certain.
However, in light of recent work [42], another possibility is that the animal models used (rats vs. mice) could be responsible for these differences. The alcohol-induced increase in GABA release upon acute CRF application in the CeA is an effect we previously demonstrated in many species including mice, rats, and non-human primates [10,17,31,32,43]. In rats, this increase in GABA in the CeA was implicated in excessive alcohol drinking of dependent animals, and this effect is mediated by locally projecting CRF neurons in the CeA [44,45,46]. However, in mice, chemogenetic activation or inhibition of these local CeA CRF neurons had no effect on alcohol consumption [42], whereas modulation of BNST CRF neurons suppressed binge drinking [47]. Thus, the involvement of the CeA CRF system in alcohol dependence may be species-dependent, and this difference in CRF system functioning could explain the discrepancies between the rat and mouse data, including the dichotomous sex differences.
Overall, our findings provide insight into the function of the CRF/CRF1 system on GABAergic transmission in the CeA of females and identify maladaptations in this system that occur during alcohol dependence. More work is needed to provide a greater overall insight into the mechanisms by which the CRF system modulates excitatory–inhibitory balance within the CeA, as this system has yet to be studied in the context of female glutamatergic transmission [33].
4. Materials and Methods
4.1. Animals
Female (N = 45) and male (N = 40) Sprague Dawley rats (Charles River, Raleigh, NC, USA) weighed on average 257.2 ± 9.3 g and 354.85 ± 16.9 g, respectively, at time of sacrifice. Estrous cycle was determined before euthanasia, but not selected for. All rats were housed in a temperature- and humidity-controlled room on a 12 h light/dark cycle with food and water available ad libitum. Alcohol-dependent rats (average blood alcohol level 172.68 ± 17.4 mg/dL at time of sacrifice) were generated by exposure to alcohol vapor daily (14 h alcohol vapor; 10 h air vapor) for 5–7 weeks [30,48,49,50] Female (N = 6) and male (N = 6) Wistar rats (Charles River, Raleigh, NC, USA) weighed on average 253.17 ± 12.7 g and 387.67 ± 24.5 g, respectively, at time of sacrifice. All procedures and care were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were reviewed and approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute.
4.2. Electrophysiology
Preparation of acute brain slices and electrophysiological recordings were performed as previously described [17,30,51,52]. Rats were deeply anesthetized with isoflurane (3–5%) before decapitation and brain isolation. Coronal CeA slices (300 μm) were prepared using a Leica VT1200 vibratome (Leica Biosystems, Deer Park, IL, USA) in an ice-cold high-sucrose cutting solution (sucrose 206 mM; KCl 2.5 mM; CaCl2•2H2O 0.5 mM; MgCl2 7 mM; NaH2PO4 1.2 mM; NaHCO3 26 mM; glucose 5 mM; HEPES 5 mM; Sigma-Aldrich, St. Louis, MO, USA). Slices were incubated and superfused (flow rate of 2–4 mL/min) with carbogen (95% O2/5% CO2) equilibrated artificial cerebrospinal fluid (aCSF; in mM: 130 NaCl, 24 NaHCO3, 10 glucose, 1.5 MgSO4•7H2O, 3.5 KCl, 1.25 NaH2PO4•H2O, 2 CaCl2•2H2O; Sigma-Aldrich, St. Louis, MO, USA). Whole-cell patch-clamp recordings of GABAergic spontaneous inhibitory postsynaptic currents (sIPSCs) were performed in neurons from the medial subdivision of the CeA clamped at −60 mV. Patch pipettes (3 to 6 MΩ) were filled with an internal solution composed of (in mM; Sigma-Aldrich, St. Louis, MO, USA): 145 KCl, 0.5 EGTA, 2 MgCl2, 10 HEPES, 2 Mg-ATP, and 0.2 Na-GTP. For animal variability, each experimental group contained neurons from a minimum of 3–4 rats. GABAergic activity was pharmacologically isolated with 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX), 30 μM DL-2-amino-5-phosphonovalerate (DL-AP5), and 1 μM CGP 55845A. In all experiments, cells with a series resistance greater than 20 MΩ were excluded from analysis, and series resistance was periodically monitored during gap-free recording with a 10 mV pulse. Cells in which series resistance changed more than 25% during the experiment were excluded from analysis. Data were analyzed using Mini Analysis (Synaptosoft Inc., Fort Lee, NJ, USA) with 3-min bins of gap-free recording. All drugs were applied by bath superfusion.
4.3. Drugs
CRF, CGP 55845A, DL-AP5, and DNQX were obtained from Tocris (Ellisville, MO, USA). Drugs were added to the aCSF from stock solutions to obtain known concentrations in the superfusate. Stock solutions of AP-5, CGP 55845A and CRF were prepared in distilled water, while DNQX and R121919 hydrochloride (R12) were dissolved in 100% DMSO. All drugs were applied to the bath solution to achieve the final desired concentrations. The final DMSO concentration in the bath solution did not exceed 0.15%.
4.4. In Situ Hybridization and Confocal Microscopy
Male and female Wistar rats (3 per treatment group) were anesthetized with isoflurane and transcardially perfused with ice-cold phosphate-buffered saline (PBS) followed by Z-fix (Fisher Scientific, Waltham, MA, USA). Brains were dissected, immersion fixed in Z-fix at 4 °C for 24 h, cryoprotected in 30% sucrose in PBS at 4 °C for 24–48 h, flash frozen in isopentane on dry ice, and stored at −80° C. Brains were then sliced on a cryostat into 20 µm thick sections, mounted on SuperFrost Plus slides (Fisher Scientific, Waltham, MA, USA; Catalog No. 1255015), and stored at −80 °C until use. In situ hybridization was performed using RNAscope fluorescent multiplex kit (ACD Bio-techne, Newark, CA, USA; Catalog No. 320850) as previously described [53]. Briefly, target retrieval pretreatment was performed according to the RNAscope manual, where slides were submerged at 95–98 °C for 10 min in target retrieval buffer (ACD, Catalog No. 322000), immediately rinsed in distilled water, and then dehydrated in ethanol (stored at −80 °C if needed), followed by incubation at 40 °C for 20 min with protease IV. Next, the RNAScope Fluorescent Multiplex Reagent Kit User Manual was followed exactly. Lastly, slides were mounted and coverslipped with Vectashield + DAPI (Fisher Scientific, Fair Lawn Industrial Park, NJ, USA). The probes used from ACD Bio-techne were as follows: 3-plex negative control (ACD, Catalog No. 320871), Crhr1 (ACD, Catalog No. 318911-C1), and Gad2 (ACD, Catalog No. 435801-C2).
Images of the CeA were acquired with a Zeiss LSM 780 laser scanning confocal microscope (40X oil immersion, 1024 × 1024 pixel, 5 μm z-stacks). All microscope settings were kept the same within experiments. Quantification was performed with the image analysis software CellProfiler [54] using the recommended guidelines for analysis of RNAscope images by ACD Biotechne with background (negative control) subtraction. Nuclei were considered positive if they contained one or more puncta after thresholding out any background. Images were visually inspected for accuracy if required. The percent of positive nuclei was calculated for each probe, and in instances of multiple treatment group comparisons, data were normalized to the control/naïve group to show relative values. Outliers were detected with Grubb’s test. Analysis was performed on raw images, and brightness/contrast/pixel dilation are the same for all representative images shown per figure.
4.5. Statistical Analysis
Data are presented as Mean ± SEM of either raw values or were normalized to the baseline values, and n refers to the number of cells, while N refers to the number of used rats (exact values are indicated for each experiment). To avoid pseudo-replication (i.e., collecting multiple samples from an individual animal), no more than 3 data points were collected from any single animal. The criterion for statistical significance was p < 0.05. Statistical analyses were performed in Prism 9 (GraphPad Software, La Jolla, CA, USA). Data were analyzed with two-way ANOVA (Alcohol Exposure × Sex or Sex × CRF Concentration) followed by Šídák’s post-hoc comparisons (when appropriate.) Changes over baseline (e.g., agonist/drug responses) were assessed using one-sample t-tests where indicated.
Appendix A
Table A1.
Alcohol Exposure | Sex | sIPSC Property | Baseline | 100 nM CRF | Baseline | 200 nM CRF | Baseline | 400 nM CRF | Baseline | R121919 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | |||
Naïve | Male | Frequency (Hz) | 2.99 | 0.68 | 3.93 | 0.99 | 1.13 | 0.23 | 1.85 | 0.38 | 3.14 | 0.90 | 3.63 | 1.02 | 3.16 | 0.77 | 2.86 | 0.68 |
Amplitude (pA) | 62.98 | 7.63 | 61.77 | 6.76 | 70.07 | 10.07 | 66.88 | 6.86 | 59.91 | 6.25 | 56.49 | 5.68 | 79.49 | 9.00 | 81.41 | 10.59 | ||
Rise Time (ms) | 2.57 | 0.13 | 2.59 | 0.11 | 2.61 | 0.14 | 2.54 | 0.10 | 2.55 | 0.08 | 2.61 | 0.12 | 2.33 | 0.08 | 2.49 | 0.11 | ||
Decay Time (ms) | 9.46 | 1.16 | 9.68 | 0.84 | 9.68 | 0.84 | 8.23 | 1.04 | 9.41 | 0.85 | 9.61 | 0.80 | 10.28 | 1.27 | 11.32 | 1.43 | ||
n | 9 | 12 | 11 | 9 | ||||||||||||||
Female | Frequency (Hz) | 1.48 | 0.36 | 1.52 | 0.28 | 1.73 | 0.58 | 1.61 | 0.49 | 1.52 | 0.34 | 1.94 | 0.58 | 2.25 | 0.58 | 2.01 | 0.51 | |
Amplitude (pA) | 66.42 | 5.97 | 64.47 | 6.52 | 65.71 | 5.13 | 66.58 | 4.94 | 57.95 | 5.77 | 69.99 | 9.01 | 68.21 | 6.96 | 65.28 | 6.99 | ||
Rise Time (ms) | 2.73 | 0.11 | 2.60 | 0.11 | 2.04 | 0.11 | 2.19 | 0.15 | 2.65 | 0.12 | 2.65 | 0.10 | 2.84 | 0.16 | 3.01 | 0.19 | ||
Decay Time (ms) | 7.47 | 0.82 | 7.77 | 0.87 | 5.92 | 0.81 | 6.57 | 1.03 | 7.76 | 1.27 | 8.74 | 1.19 | 9.95 | 0.98 | 11.30 | 1.07 | ||
n | 10 | 9 | 8 | 10 | ||||||||||||||
Dependent | Male | Frequency (Hz) | 3.30 | 0.40 | 3.56 | 0.47 | 1.43 | 0.29 | 2.25 | 0.68 | 2.63 | 0.54 | 3.14 | 0.68 | 1.79 | 0.42 | 1.48 | 0.37 |
Amplitude (pA) | 85.01 | 10.06 | 83.44 | 13.25 | 61.75 | 7.82 | 62.05 | 7.78 | 80.04 | 10.23 | 78.06 | 12.82 | 57.55 | 6.56 | 59.45 | 6.47 | ||
Rise Time (ms) | 2.42 | 0.06 | 2.48 | 0.06 | 2.63 | 0.09 | 2.61 | 0.10 | 2.56 | 0.07 | 2.56 | 0.06 | 3.14 | 0.16 | 3.09 | 0.18 | ||
Decay Time (ms) | 10.20 | 1.03 | 10.16 | 0.92 | 9.71 | 1.44 | 8.87 | 1.28 | 10.61 | 0.72 | 9.91 | 0.87 | 12.68 | 1.20 | 13.04 | 1.02 | ||
n | 9 | 9 | 11 | 10 | ||||||||||||||
Female | Frequency (Hz) | 2.42 | 0.56 | 2.42 | 0.56 | 1.50 | 0.21 | 2.57 | 0.57 | 1.63 | 0.23 | 2.13 | 0.37 | 1.93 | 0.62 | 1.68 | 0.48 | |
Amplitude (pA) | 59.18 | 3.40 | 53.49 | 2.23 | 95.01 | 15.07 | 112.62 | 21.57 | 62.84 | 8.16 | 68.50 | 15.50 | 71.30 | 12.03 | 62.58 | 9.93 | ||
Rise Time (ms) | 2.82 | 0.25 | 2.73 | 0.27 | 2.23 | 0.09 | 2.29 | 0.07 | 2.61 | 0.19 | 2.72 | 0.20 | 3.10 | 0.18 | 3.19 | 0.16 | ||
Decay Time (ms) | 12.09 | 1.15 | 10.84 | 1.17 | 8.45 | 0.88 | 9.15 | 1.11 | 10.81 | 0.86 | 10.14 | 0.95 | 11.47 | 1.28 | 11.70 | 1.14 | ||
n | 8 | 11 | 9 | 9 |
Author Contributions
Conceptualization, D.K., L.R. and M.R.; methodology, L.R., D.K., S.A.W. and M.R.; formal analysis, L.R., D.K., S.A.W., R.R.P., F.P.V., A.E.S., P.J.G., S.K., R.V. and M.B.; investigation, L.R., D.K., S.A.W., R.R.P., F.P.V., A.E.S., P.J.G., S.K., R.V. and M.B.; resources, M.R.; data curation, L.R., D.K., S.A.W. and M.R.; writing—original draft preparation, L.R., D.K., S.A.W. and M.R.; writing—review and editing, L.R., D.K., S.A.W., R.R.P., F.P.V., A.E.S., P.J.G., S.K., R.V., M.B. and M.R.; visualization, L.R. and D.K.; supervision, M.R.; project administration, M.R.; funding acquisition, D.K. and M.R. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
The animal study protocol was approved by the Institutional Review Board of The Scripps Research Institute (IACUC 09-0006; approved 20 August 2020).
Informed Consent Statement
Not applicable.
Data Availability Statement
The data underlying this article will be shared upon reasonable request to the corresponding author.
Conflicts of Interest
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Funding Statement
This research was funded by NIH/NIAAA grants AA026638, AA027700, AA015566, AA021491, AA017447, AA006420, AA013498, AA026765, AA007456, AA029841, AA025408, and The Pearson Center for Alcoholism and Addiction Research. This is manuscript number 30185 from The Scripps Research Institute.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Koob G.F., Buck C.L., Cohen A., Edwards S., Park P.E., Schlosburg J.E., Schmeichel B., Vendruscolo L.F., Wade C.L., Whitfield T.W., Jr., et al. Addiction as a stress surfeit disorder. Neuropharmacology. 2014;76 Pt B:370–382. doi: 10.1016/j.neuropharm.2013.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Koob G.F. Current Topics in Behavioral Neurosciences. Springer; Berlin/Heidelberg, Germany: 2022. Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders. [DOI] [PubMed] [Google Scholar]
- 3.Zorrilla E.P., Koob G.F. Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov. Today. 2010;15:371–383. doi: 10.1016/j.drudis.2010.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gilpin N.W., Roberto M. Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. Neurosci. Biobehav. Rev. 2012;36:873–888. doi: 10.1016/j.neubiorev.2011.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lowery E.G., Thiele T.E. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol. Disord. Drug Targets. 2010;9:77–86. doi: 10.2174/187152710790966605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Roberto M., Spierling S.R., Kirson D., Zorrilla E.P. Corticotropin-Releasing Factor (CRF) and Addictive Behaviors. Int. Rev. Neurobiol. 2017;136:5–51. doi: 10.1016/bs.irn.2017.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Quadros I.M., Macedo G.C., Domingues L.P., Favoretto C.A. An Update on CRF Mechanisms Underlying Alcohol Use Disorders and Dependence. Front. Endocrinol. 2016;7:134. doi: 10.3389/fendo.2016.00134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Roberto M., Gilpin N.W., Siggins G.R. The central amygdala and alcohol: Role of Gamma-Aminobutyric acid, glutamate, and neuropeptides. Cold Spring Harb. Perspect. Med. 2012;2:a012195. doi: 10.1101/cshperspect.a012195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Koob G.F. Theoretical frameworks and mechanistic aspects of alcohol addiction: Alcohol addiction as a reward deficit disorder. Curr. Top. Behav. Neurosci. 2013;13:3–30. doi: 10.1007/7854_2011_129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jimenez V.A., Herman M.A., Cuzon Carlson V.C., Walter N.A., Grant K.A., Roberto M. Synaptic adaptations in the central amygdala and hypothalamic paraventricular nucleus associated with protracted ethanol abstinence in male rhesus monkeys. Neuropsychopharmacology. 2019;44:982–993. doi: 10.1038/s41386-018-0290-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Roberto M., Kirson D., Khom S. The Role of the Central Amygdala in Alcohol Dependence. Cold Spring Harb. Perspect. Med. 2021;11:a039339. doi: 10.1101/cshperspect.a039339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bale T.L., Vale W.W. CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004;44:525–557. doi: 10.1146/annurev.pharmtox.44.101802.121410. [DOI] [PubMed] [Google Scholar]
- 13.Hauger R.L., Risbrough V., Brauns O., Dautzenberg F.M. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets. CNS Neurol. Disord. Drug Targets. 2006;5:453–479. doi: 10.2174/187152706777950684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Heilig M., Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007;30:399–406. doi: 10.1016/j.tins.2007.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Fekete E.M., Zorrilla E.P. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs. Front. Neuroendocrinol. 2007;28:1–27. doi: 10.1016/j.yfrne.2006.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Merlo Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 1995;15:5439–5447. doi: 10.1523/JNEUROSCI.15-08-05439.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Roberto M., Cruz M.T., Gilpin N.W., Sabino V., Schweitzer P., Bajo M., Cottone P., Madamba S.G., Stouffer D.G., Zorrilla E.P., et al. Corticotropin releasing factor-induced amygdala Gamma-Aminobutyric Acid release plays a key role in alcohol dependence. Biol. Psychiatry. 2010;67:831–839. doi: 10.1016/j.biopsych.2009.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Valdez G.R., Zorrilla E.P., Roberts A.J., Koob G.F. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol. 2003;29:55–60. doi: 10.1016/S0741-8329(03)00020-X. [DOI] [PubMed] [Google Scholar]
- 19.Gehlert D.R., Cippitelli A., Thorsell A., Le A.D., Hipskind P.A., Hamdouchi C., Lu J., Hembre E.J., Cramer J., Song M., et al. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo [1,2-b]pyridazine: A novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J. Neurosci. 2007;27:2718–2726. doi: 10.1523/JNEUROSCI.4985-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Richardson H.N., Zhao Y., Fekete E.M., Funk C.K., Wirsching P., Janda K.D., Zorrilla E.P., Koob G.F. MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol. Biochem. Behav. 2008;88:497–510. doi: 10.1016/j.pbb.2007.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Overstreet D.H., Knapp D.J., Breese G.R. Similar anxiety-like responses in male and female rats exposed to repeated withdrawals from ethanol. Pharmacol. Biochem. Behav. 2004;78:459–464. doi: 10.1016/j.pbb.2004.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kwako L.E., Spagnolo P.A., Schwandt M.L., Thorsell A., George D.T., Momenan R., Rio D.E., Huestis M., Anizan S., Concheiro M., et al. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: A randomized controlled experimental medicine study. Neuropsychopharmacology. 2015;40:1053–1063. doi: 10.1038/npp.2014.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Schwandt M.L., Cortes C.R., Kwako L.E., George D.T., Momenan R., Sinha R., Grigoriadis D.E., Pich E.M., Leggio L., Heilig M. The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects. Neuropsychopharmacology. 2016;41:2818–2829. doi: 10.1038/npp.2016.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Steinman M.Q., Kirson D., Wolfe S.A., Khom S., D’Ambrosio S.R., Spierling Bagsic S.R., Bajo M., Vlkolinsky R., Hoang N.K., Singhal A., et al. Importance of sex and trauma context on circulating cytokines and amygdalar GABAergic signaling in a comorbid model of posttraumatic stress and alcohol use disorders. Mol. Psychiatry. 2021;26:3093–3107. doi: 10.1038/s41380-020-00920-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kirson D., Steinman M.Q., Wolfe S.A., Spierling Bagsic S.R., Bajo M., Sureshchandra S., Oleata C.S., Messaoudi I., Zorrilla E.P., Roberto M. Sex and context differences in the effects of trauma on comorbid alcohol use and post-traumatic stress phenotypes in actively drinking rats. J. Neurosci. Res. 2021;99:3354–3372. doi: 10.1002/jnr.24972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Shansky R.M. Sex differences in PTSD resilience and susceptibility: Challenges for animal models of fear learning. Neurobiol. Stress. 2015;1:60–65. doi: 10.1016/j.ynstr.2014.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wellman C.L., Bangasser D.A., Bollinger J.L., Coutellier L., Logrip M.L., Moench K.M., Urban K.R. Sex Differences in Risk and Resilience: Stress Effects on the Neural Substrates of Emotion and Motivation. J. Neurosci. 2018;38:9423–9432. doi: 10.1523/JNEUROSCI.1673-18.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cover K.K., Maeng L.Y., Lebron-Milad K., Milad M.R. Mechanisms of estradiol in fear circuitry: Implications for sex differences in psychopathology. Transl. Psychiatry. 2014;4:e422. doi: 10.1038/tp.2014.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Agoglia A.E., Tella J., Herman M.A. Sex differences in corticotropin releasing factor peptide regulation of inhibitory control and excitability in central amygdala corticotropin releasing factor receptor 1-neurons. Neuropharmacology. 2020;180:108296. doi: 10.1016/j.neuropharm.2020.108296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kirson D., Khom S., Rodriguez L., Wolfe S.A., Varodayan F.P., Gandhi P.J., Patel R.R., Vlkolinsky R., Bajo M., Roberto M. Sex Differences in Acute Alcohol Sensitivity of Naive and Alcohol Dependent Central Amygdala GABA Synapses. Alcohol Alcohol. 2021;56:581–588. doi: 10.1093/alcalc/agab034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science. 2004;303:1512–1514. doi: 10.1126/science.1092550. [DOI] [PubMed] [Google Scholar]
- 32.Nie Z., Zorrilla E.P., Madamba S.G., Rice K.C., Roberto M., Siggins G.R. Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala. Sci. World J. 2009;9:68–85. doi: 10.1100/tsw.2009.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Varodayan F.P., Correia D., Kirson D., Khom S., Oleata C.S., Luu G., Schweitzer P., Roberto M. CRF modulates glutamate transmission in the central amygdala of naive and ethanol-dependent rats. Neuropharmacology. 2017;125:418–428. doi: 10.1016/j.neuropharm.2017.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Varodayan F.P., Logrip M.L., Roberto M. P/Q-type voltage-gated calcium channels mediate the ethanol and CRF sensitivity of central amygdala GABAergic synapses. Neuropharmacology. 2017;125:197–206. doi: 10.1016/j.neuropharm.2017.07.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Varodayan F.P., de Guglielmo G., Logrip M.L., George O., Roberto M. Alcohol Dependence Disrupts Amygdalar L-Type Voltage-Gated Calcium Channel Mechanisms. J. Neurosci. 2017;37:4593–4603. doi: 10.1523/JNEUROSCI.3721-16.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rouzer S.K., Diaz M.R. Factors of sex and age dictate the regulation of GABAergic activity by corticotropin-releasing factor receptor 1 in the medial sub-nucleus of the central amygdala. Neuropharmacology. 2021;189:108530. doi: 10.1016/j.neuropharm.2021.108530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Agoglia A.E., Zhu M., Quadir S.G., Bluitt M.N., Douglass E., Hanback T., Tella J., Ying R., Hodge C.W., Herman M.A. Sex-specific plasticity in CRF regulation of inhibitory control in central amygdala CRF1 neurons after chronic voluntary alcohol drinking. Addict. Biol. 2022;27:e13067. doi: 10.1111/adb.13067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Retson T.A., Hoek J.B., Sterling R.C., Van Bockstaele E.J. Amygdalar neuronal plasticity and the interactions of alcohol, sex, and stress. Brain Struct. Funct. 2015;220:3211–3232. doi: 10.1007/s00429-014-0851-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Herman M.A., Roberto M. Cell-type-specific tonic GABA signaling in the rat central amygdala is selectively altered by acute and chronic ethanol. Addict. Biol. 2016;21:72–86. doi: 10.1111/adb.12181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Herman M.A., Contet C., Roberto M. A Functional Switch in Tonic GABA Currents Alters the Output of Central Amygdala Corticotropin Releasing Factor Receptor-1 Neurons Following Chronic Ethanol Exposure. J. Neurosci. 2016;36:10729–10741. doi: 10.1523/JNEUROSCI.1267-16.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Augier E., Barbier E., Dulman R.S., Licheri V., Augier G., Domi E., Barchiesi R., Farris S., Natt D., Mayfield R.D., et al. A molecular mechanism for choosing alcohol over an alternative reward. Science. 2018;360:1321–1326. doi: 10.1126/science.aao1157. [DOI] [PubMed] [Google Scholar]
- 42.Kreifeldt M., Herman M.A., Sidhu H., Okhuarobo A., Macedo G.C., Shahryari R., Gandhi P.J., Roberto M., Contet C. Central amygdala corticotropin-releasing factor neurons promote hyponeophagia but do not control alcohol drinking in mice. Mol. Psychiatry. 2022;27:2502–2513. doi: 10.1038/s41380-022-01496-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Patel R.R., Varodayan F.P., Herman M.A., Jimenez V., Agnore R., Gao L., Bajo M., Cuzon Carlson V.C., Walter N.A., Fei S.S., et al. Synaptic effects of IL-1beta and CRF in the central amygdala after protracted alcohol abstinence in male rhesus macaques. Neuropsychopharmacology. 2022;47:847–856. doi: 10.1038/s41386-021-01231-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Pomrenze M.B., Millan E.Z., Hopf F.W., Keiflin R., Maiya R., Blasio A., Dadgar J., Kharazia V., De Guglielmo G., Crawford E., et al. A Transgenic Rat for Investigating the Anatomy and Function of Corticotrophin Releasing Factor Circuits. Front. Neurosci. 2015;9:487. doi: 10.3389/fnins.2015.00487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Pomrenze M.B., Giovanetti S.M., Maiya R., Gordon A.G., Kreeger L.J., Messing R.O. Dissecting the Roles of GABA and Neuropeptides from Rat Central Amygdala CRF Neurons in Anxiety and Fear Learning. Cell Rep. 2019;29:13–21.e4. doi: 10.1016/j.celrep.2019.08.083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.de Guglielmo G., Kallupi M., Pomrenze M.B., Crawford E., Simpson S., Schweitzer P., Koob G.F., Messing R.O., George O. Inactivation of a CRF-dependent amygdalofugal pathway reverses addiction-like behaviors in alcohol-dependent rats. Nat. Commun. 2019;10:1238. doi: 10.1038/s41467-019-09183-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Pleil K.E., Rinker J.A., Lowery-Gionta E.G., Mazzone C.M., McCall N.M., Kendra A.M., Olson D.P., Lowell B.B., Grant K.A., Thiele T.E., et al. NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat. Neurosci. 2015;18:545–552. doi: 10.1038/nn.3972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kirson D., Oleata C.S., Roberto M. Taurine Suppression of Central Amygdala GABAergic Inhibitory Signaling via Glycine Receptors Is Disrupted in Alcohol Dependence. Alcohol. Clin. Exp. Res. 2020;44:445–454. doi: 10.1111/acer.14252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Khom S., Nguyen J.D., Vandewater S.A., Grant Y., Roberto M., Taffe M.A. Self-Administration of Entactogen Psychostimulants Dysregulates Gamma-Aminobutyric Acid (GABA) and Kappa Opioid Receptor Signaling in the Central Nucleus of the Amygdala of Female Wistar Rats. Front. Behav. Neurosci. 2021;15:780500. doi: 10.3389/fnbeh.2021.780500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Khom S., Steinkellner T., Hnasko T.S., Roberto M. Alcohol dependence potentiates substance P/neurokinin-1 receptor signaling in the rat central nucleus of amygdala. Sci. Adv. 2020;6:eaaz1050. doi: 10.1126/sciadv.aaz1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Khom S., Rodriguez L., Gandhi P., Kirson D., Bajo M., Oleata C.S., Vendruscolo L.F., Mason B.J., Roberto M. Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in male rats. Neurobiol. Dis. 2022;164:105610. doi: 10.1016/j.nbd.2022.105610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Varodayan F.P., Patel R.R., Matzeu A., Wolfe S.A., Curley D.E., Khom S., Gandhi P.J., Rodriguez L., Bajo M., D’Ambrosio S., et al. The Amygdala Noradrenergic System Is Compromised with Alcohol Use Disorder. Biol. Psychiatry. 2022;91:1008–1018. doi: 10.1016/j.biopsych.2022.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Wolfe S.A., Sidhu H., Patel R.R., Kreifeldt M., D’Ambrosio S.R., Contet C., Roberto M. Molecular, Morphological, and Functional Characterization of Corticotropin-Releasing Factor Receptor 1-Expressing Neurons in the Central Nucleus of the Amygdala. eNeuro. 2019;6:e0087-19.2019. doi: 10.1523/ENEURO.0087-19.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Jones T.R., Kang I.H., Wheeler D.B., Lindquist R.A., Papallo A., Sabatini D.M., Golland P., Carpenter A.E. CellProfiler Analyst: Data exploration and analysis software for complex image-based screens. BMC Bioinform. 2008;9:482. doi: 10.1186/1471-2105-9-482. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data underlying this article will be shared upon reasonable request to the corresponding author.